Asthma project

In collaboration with Teva Pharmaceuticals  we have co designed the CareTRx Programme which aims to understand how an innovative combination of digital technology, behavioural change science and patient support services can be of benefit to patients in the self-management of their asthma condition.

Asthmatic patients from a number of pilot GP practices in Sheffield are being invited to take part in the pilot programme.

Patients attend a CareTRx Clinic with a respiratory nurse specialist. At the clinic details of the Test Bed and CareTRx Programme are explained and how the programme may be of benefit to them in managing their asthma.

Each patient has access to a CareTRx Sensor that can be attached to their inhaler and a smartphone App. The programme enables patients to monitor their dosage, receive notifications, and view statistics on how often they’re taking their medicine. Data is also sent to a case management dashboard, where healthcare professionals can identify high-risk patients. There is also a dedicated nurse call centre as well as a website which provides tools and advice to support patients to manage their asthma.

Why are we doing this?

The current objective is to understand how patients and clinicians engage with this new approach to asthma management with a view to it being integrated into the lives of patients and care pathways if the evaluation is positive, to do this the CareTRx Programme will evolve to meet the needs of patients with asthma as the pilot programme progresses.

Non-adherence to maintenance medication in asthma is estimated to be between 30% and 70%1 and new approaches are needed to address this challenge and the issue of ineffective inhaler use.  Maintenance treatments regimens need to be adhered to by patients’ ≥80% to achieve the greatest asthma control2

Who is involved in this project?

Lead Evaluation Partner: University of Sheffield  (https://www.sheffield.ac.uk/scharr)

Lead for public engagement: Healthwatch Sheffield (http://www.healthwatchsheffield.co.uk/)

Lead Innovator Partner: Teva Pharmaceuticals (http://www.tevapharm.com/)

GP Practices involved:

  • Dover Court Surgery
  • Greystones Medical Centre
  • Nethergreen Surgery
  • The Hollies Medical Centre
  • Woodhouse Medical Centre
  • Sheffield University Practice
  • Porterbrook Medical Centre
  • The White House Surgery
  • The Crookes Practice
  • Birley Medical Centre
  • The Walkley House Medical Practice
  • Mill Road Surgery
  • Tramways Medical Centre
  • Gleadless Medical Centre
  • Firth Park Surgery

What happens next?

Recruitment of patients into the programme will continue until the end of January 2018.  The programme will formally end in June 2018 and a final evaluation report will be available from the end of June 2018.

 

 

CareTRx

References

  1. World Health Organisation. Adherence to long-term therapies: evidence for action [Internet]. WHO. 2003 [cited 2016 Mar 29]. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en
  2. Lasmar L, Camargos P, Champs NS, Fonseca MT, Fontes MJ, Ibiapina C, et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy. 2009 May 1;64(5):784–9.